The distal nephron biomarkers associate with diabetic kidney disease progression
Tamargo C, Coca S, Philbrook H, Hu D, Ix J, Shlipak M, Fried L, Gutierrez O, Waikar S, Schrauben S, Schelling J, Ganz P, Kimmel P, Greenberg J, Deo R, Takakura A, Vasan R, Bonventre J, Parikh C. The distal nephron biomarkers associate with diabetic kidney disease progression. JCI Insight 2025, 10: e186836. PMID: 40548378, DOI: 10.1172/jci.insight.186836.Peer-Reviewed Original ResearchConceptsDiabetic kidney disease progressionUrine albumin-to-creatinine ratioDiabetic kidney diseaseRisk of DKD progressionEpidermal growth factorDKD progressionMedian urine albumin-to-creatinine ratioUrinary epidermal growth factorBiomarker levelsAlbumin-to-creatinine ratioDistal tubule markerPredicting diabetic kidney diseaseMedian Follow-UpDistal tubular markersKidney disease progressionCox regression modelsBaseline biomarker levelsNational Institute of DiabetesType 2 diabetesEGFR changeTubular markersUrinary biomarkersFollow-upClinical trialsDisease progression
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply